NCT02693314 - Evaluation of Jarro-Dophilus EPS® Probiotic Formulations | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Healthy

Interventions

DIETARY_SUPPLEMENT

Jarro-Dophilus EPS® (5 billion CFU/capsule)

One capsule containing 5 billion CFU of the probiotic mix (Lactobacillus helveticus, Lactobacillus rhamnosus, Lactobacillus casei, Pediococcus acidilactici, Bifidobacteria breve, Bifidobacteria longum, Lactobacillus plantarum and Lactobacillus lactis ssp. lactis) will be taken once a day for a period of 28 days.

DIETARY_SUPPLEMENT

Jarro-Dophilus EPS® High Potency (25 billion CFU/capsule)

One capsule containing 25 billion CFU of the probiotic mix (Lactobacillus helveticus, Lactobacillus rhamnosus, Lactobacillus casei, Pediococcus acidilactici, Bifidobacteria breve, Bifidobacteria longum, Lactobacillus plantarum and Lactobacillus lactis ssp. lactis) will be taken once a day for a period of 28 days.

DIETARY_SUPPLEMENT

Placebo

One capsule (containing potato starch, magnesium stearate and ascorbic acid) will be taken once a day for a period of 28 days.

Trial Locations (1)

32611

Food Science and Human Nutrition Department, University of Florida, Gainesville